• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2026, Vol. 28 ›› Issue (5): 733-739.DOI: 10.3969/j.issn.1671-2587.2026.05.010

Previous Articles     Next Articles

A Large-Scale Quantitative Model of RhCE-Related Transfusion Alloimmunization Risk in the Chinese Population

YU Jian, LI Xinglong, TU Jiaxin, BAO Likun, ZHU Changtai   

  1. Department of Blood Transfusion, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233
  • Received:2026-09-05 Revised:2026-09-21 Online:2026-10-20 Published:2026-11-11

Abstract: Objective To quantify the cumulative probability of novel antigen exposure and model-based immunological risk among individuals with distinct RhCE phenotypes under random transfusion conditions, thereby providing a quantitative rationale for proposed precision transfusion strategies. Methods This was a secondary analysis. We pooled RhD, C, c, E, and e antigen typing data from 458 542 Chinese individuals across eight studies reported by Zhao Tongmao, and confirmed Hardy-Weinberg equilibrium. Maximum-likelihood estimation was used to derive Rh haplotype frequencies and RHCE allele frequencies. On this basis, an independent-event cumulative probability model was applied to calculate the cumulative novel antigen exposure probability for nine RhD-positive phenotypes across one to five random transfusions, and a weighted immunological Risk Index (RI) was constructed to comprehensively assess the alloimmunization risk of each phenotype. The RI is a composite model-derived score and does not equate to the observed incidence of alloimmunization. Results The most common haplotype in the Chinese population was DCe (65.80%), followed by DcE (24.77%). The DCCee phenotype (46.00% of the population) represented the highest-risk group, with a single-transfusion novel antigen (E, c) exposure probability of 53.77%, rising to 97.89% after five transfusions, and a model-derived RI of approximately 43.95, classified as high risk by the model definition. The DCcEe phenotype (33.58% of the population), owing to its simultaneous carriage of C, c, E, and e antigens, had a transfusion-related RhCE novel antigen exposure probability of 0% under the conditions of this model; however, this applies only to the RhCE system and does not render such individuals universal recipients. For e antigen-negative homozygous phenotypes (e.g., DCcEE), random transfusion makes e antigen exposure virtually inevitable, with cumulative probability approaching 100% after multiple transfusions; nevertheless, because of the extremely low immunogenicity of the e antigen (weight 0.071), the model-derived RI remained limited. Conclusion The distribution of RhCE phenotypes in the Chinese population is highly uneven, and the DCCee phenotype constitutes the primary target population for proposed precision transfusion strategies. Model results indicate that both L1-A targeted antigen avoidance and L1-B (C/c/E/e) complete phenotype matching can reduce the probability of target RhCE novel antigen exposure to 0%; however, the two approaches differ in donor pool size and clinical feasibility, and neither should be equated with complete elimination of clinical alloimmunization risk. The DCcEe phenotype can be regarded as a "pan-antigen carrier" only within the RhCE system and is not a clinically universal recipient; alloimmunization against other blood group systems remains possible. Based on these model projections, we recommend that RhCE typing be progressively incorporated into pre-transfusion testing, and that RhCE-matched proposed strategies be initiated as early as possible for high-risk phenotypes and patients requiring long-term transfusion, so as to minimize the risk of alloimmunization; these specific strategies warrant further validation in multicenter prospective studies.

Key words: Rh blood group system, RhCE antigen matching, Precision transfusion, Alloimmunization, Hardy-Weinberg equilibrium, Immune risk index

CLC Number: